Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

Clinical trial NCT00217399 · COMPLETED

Trial details

NCT number: NCT00217399
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2005-06-01
Primary completion: 2009-07-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.